Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2013 Jul;4(3):134-40.
doi: 10.4103/2231-4040.116779.

Informed consent: Issues and challenges

Lokesh P Nijhawan  1 , Manthan D Janodia, B S Muddukrishna, K M Bhat, K L Bairy, N Udupa, Prashant B Musmade
Affiliations
Review

Informed consent: Issues and challenges

Lokesh P Nijhawan et al. J Adv Pharm Technol Res. 2013 Jul.

Abstract

Informed consent is an ethical and legal requirement for research involving human participants. It is the process where a participant is informed about all aspects of the trial, which are important for the participant to make a decision and after studying all aspects of the trial the participant voluntarily confirms his or her willingness to participate in a particular clinical trial and significance of the research for advancement of medical knowledge and social welfare. The concept of informed consent is embedded in the principles of Nuremberg Code, The Declaration of Helsinki and The Belmont Report. Informed consent is an inevitable requirement prior to every research involving human being as subjects for study. Obtaining consent involves informing the subject about his or her rights, the purpose of the study, procedures to be undertaken, potential risks and benefits of participation, expected duration of study, extent of confidentiality of personal identification and demographic data, so that the participation of subjects in the study is entirely voluntary. This article provides an overview of issues in informed consent: The obligations of investigator, sponsor and Institutional Review Board to protect rights and welfare of human research subjects. It discusses about the basic elements of informed consent and the process to be followed while obtaining informed consent. Some of the circumstances under which informed consent can be waived and ethical challenges faced by physicians in obtaining informed consent from subjects are also highlighted in this article.

Keywords: Human subjects; informed consent; institutional review board.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest: Nil.

Figures

Figure 1
Figure 1
Flow chart regarding various informed consent processes
See this image and copyright information in PMC

References

    1. International conference on harmonisation of technical requirements for registration of pharmaceuticals for human use. Guideline for good clinical practice E6(R1) June. 1996. [Last accessed on 2011 Apr 19]. Available from: http://www.ich.org/fileadmin/Public_Web_Site/ICH_Products/Guidelines/Eff... .
    1. Berry IR. New York: Marcel Dekker; 2005. The Pharmaceutical Regulatory Process.
    1. Lee C, Lee LH, Wu CL, Lee BR, Chen ML. Florida: CRC Press, Taylor and Francis Groups; 2006. Clinical Trials of Drugs and Biopharmaceuticals.
    1. The Nuremberg code (1947) [Last accessed on 2011 Apr 19];Br Med J. 1996 313:1448. Available from: http://www.cirp.org/library/ethics/nuremberg .
    1. World Medical Association declaration of Helsinki. Ethical principles for medical research involving human subjects. [Last accessed on 2011 Apr 20]. Available from: http://www.ohsr.od.nih.gov/guidelines/helsinki.html .

LinkOut - more resources